GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

Published 2012 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease
Authors
Keywords
-
Journal
REVIEWS IN THE NEUROSCIENCES
Volume 23, Issue 1, Pages 1-11
Publisher
Walter de Gruyter GmbH
Online
2012-03-22
DOI
10.1515/rns.2011.061

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.